Bruce I. Sachs - 06 Aug 2025 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Reporting relationship: Director
Issuer ticker: VRTX
Reported as of: 06 Aug 2025
Net transaction value: +$1,948,416
SEC form: 4
Accepted by SEC: 07 Aug 2025, 16:19:03 UTC
Prior SEC filing: 17 Jul 2025
Next SEC filing: 17 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Christiana Stevenson, Attorney-in-Fact

Key filing fact

Bruce I. Sachs filed Form 4 for VERTEX PHARMACEUTICALS INC / MA (VRTX) on 07 Aug 2025.

Key facts

This page summarizes Bruce I. Sachs's Form 4 filing for VERTEX PHARMACEUTICALS INC / MA (VRTX).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 07 Aug 2025, 16:19.

Change

Previous filing in this sequence was filed on 17 Jul 2025.
Current net transaction value: +$1,948,416.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001197036 Primary reporting owner

SACHS BRUCE I

Relationship: Director
Address: C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVE, BOSTON
Signature: /s/ Christiana Stevenson, Attorney-in-Fact
Signature date: 07 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VRTX transaction

Common Stock

Purchase

Transaction value: $636,214
Shares: +1,634
Change %: +4.1%
Price: $389.36
Shares after: 41,634
Date: 06 Aug 2025
Ownership: Direct
Footnotes: F1, F2

VRTX transaction

Common Stock

Purchase

Transaction value: $1,312,201
Shares: +3,366
Change %: +8.1%
Price: $389.84
Shares after: 45,000
Date: 06 Aug 2025
Ownership: Direct
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Open market purchases reported on this line occurred at a weighted average price of $389.36 (range $388.61 to $389.60).

Footnote F2

Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.

Footnote F3

Open market purchases reported on this line occurred at a weighted average price of $389.84 (range $389.61 to $390.00).